Sino Biopharmaceutical (OTCMKTS:SBMFF) Shares Shorted: Short Interest Down 41.2% in September

Sino Biopharmaceutical (OTCMKTS:SBMFF) saw a significant drop in short interest in September. As of September 15th, there was short interest totaling 15,082,316 shares, a drop of 41.2% from the August 31st total of 25,660,865 shares. Based on an average daily trading volume, of 530 shares, the short-interest ratio is presently 28,457.2 days. Currently, 0.1% of the company’s stock are short sold.

Sino Biopharmaceutical Stock Performance

Shares of SBMFF remained flat at $0.70 during trading hours on Wednesday. The stock had a trading volume of 2,000 shares, compared to its average volume of 198. The company’s 50 day simple moving average is $0.68 and its 200 day simple moving average is $0.69. Sino Biopharmaceutical has a 52 week low of $0.59 and a 52 week high of $1.07.

About Sino Biopharmaceutical

Sino Biopharmaceutical Limited is a China-based pharmaceutical company engaged in the research, development, manufacturing and commercialization of medicines. The company offers prescription drugs and other pharmaceutical products across areas including oncology, liver disease, respiratory conditions, digestive disorders, cardiovascular disease and orthopedics.

Its business includes generic medicines, innovative therapies, biologic products and traditional Chinese medicine. Key operating subsidiaries and research units include Chia Tai Tianqing Pharmaceutical Group, which has been associated with the development and commercialization of oncology and hepatology treatments, as well as other companies focused on pharmaceutical research, manufacturing and distribution.

Established in 2000, Sino Biopharmaceutical primarily serves the Chinese pharmaceutical market and has pursued international development and commercialization opportunities for selected products.